Vendor, Research Triangle Park, NC
Grifols Therapeutics LLC
UEI UFQ3A7GKJ5C7, CAGE 6SLC6
1 award and $613,200 obligated between September 27, 2024 and August 6, 2025, 100% under full and open competition, against 1.0 offers on average where reported.
Sells to
Awarding agencies by dollars.
| Office of Assistant Secretary for Preparedness and Response | $613,200 |
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $613,200 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75A50124C00050Definitive Contract, September 27, 2024, Full and Open Competition, 1 offers | Barda - Aspr / Daappo / Barda DCMAOffice of Assistant Secretary for Preparedness and Response | Grifols Therapeutics Llc- Ocular Surface Immunoglobulin in the Management of Vesicant Agents InjuryNAICS 541714, PSC AN13 | $613,200 |
- Places of performance
- North Carolina
- Product and service codes
- AN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 2 across 1 awards